person

Antonia S. S.

Country
Spain
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 22 partner sites.

Specializations

Breast Cancer Oncology

Investigates therapeutic strategies for hormone‑receptor positive and HER2‑negative disease as well as HER2‑positive and triple‑negative subtypes in breast cancer.

  • Hormone‑receptor positive / HER2‑negative breast cancer
  • HER2‑positive metastatic breast cancer
  • Triple‑negative breast cancer
  • Early‑stage high‑risk breast cancer

Emphasis on targeted antibodies and antibody‑drug conjugates in breast cancer.

Hematologic Malignancies

Focuses on myeloid neoplasms and plasma‑cell disorders within hematology.

  • Acute myeloid leukemia
  • Myelodysplastic syndrome
  • Chronic myelomonocytic leukemia
  • Multiple myeloma

Explores novel immunotherapies and cellular approaches for hematologic cancers.

Autoimmune and Renal Immunology

Addresses immune‑mediated kidney disease in IgA nephropathy. Investigates neuromuscular autoimmunity in myasthenia gravis.

  • IgA nephropathy
  • Lupus nephritis
  • Generalized myasthenia gravis
  • Multiple sclerosis

Investigates complement inhibition and B‑cell modulation for autoimmune disorders.

Metabolic Liver and Cardiovascular Disease

Studies progressive fatty liver disease and its cardiovascular sequelae in non‑alcoholic steatohepatitis.

  • Non‑alcoholic steatohepatitis (NASH)
  • Type 2 diabetes mellitus
  • Atherosclerotic cardiovascular disease
  • Heart failure with reduced ejection fraction

Targets metabolic pathways to reduce hepatic fibrosis and cardiovascular risk in metabolic disease.

Pulmonary and Respiratory Oncology

Explores targeted and immunologic treatments for thoracic malignancies in non‑small cell lung cancer.

  • Non‑small cell lung cancer
  • Small cell lung cancer
  • Bronchiectasis
  • Chronic obstructive pulmonary disease

Integrates biomarkers for precision therapy in lung cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.